News


HART BIOLOGICALS welcomed Dr Pall Onundarson, M.D., and Brynja Gudmundsdottir, M.S. from Iceland to give a groundbreaking talk on their latest research.

HART BIOLOGICALS has celebrated its latest achievement, in being awarded a Silver Sponsor Award from North East based charity Music v Cancer.

THE distributor meeting held by Hart Biologicals received excellent feedback from all who attended.

THIS month Hart Biologicals held its first distributor meeting, inviting companies from across the globe to come and view its production, research and quality control testing facilities.

HART INNOVATIONS Head of Research and Development Alexander Ebinger, and Scientist Christian Genz have further strengthened the company’s reputation with the education sector after attending the North East University Showcase.

HART Biologicals’ staff got the once in a life time opportunity to attend a lecture delivered by the first Briton in space.

HART Biologicals’ Wendy Foster has been promoted to Office Manager after being with the company for nearly 10 years. Hartlepool-born Wendy originally started at Hart Biologicals on a part-time basis looking after the accounts, but as the company grew, so did Wendy’s workload.

HART BIOLOGICALS has continued to strengthen its growing team by providing one-year placements for two university students.

HAEMOSTASIS specialist Hart Biologicals has welcomed Sandra Hull to the team as the company’s resident Phlebotomist.

THE Hart Biologicals team has shown its commitment to World Thrombosis Day by raising awareness through its social media channels.

Hart Biologicals will represent the UK in joining 65 Nations United on 13 October, World Thrombosis Day, to Issue Global Call on Blood Clot Risk Assessment in Hospitals Focus on patient safety calls for greater vigilance and action to help save lives by reducing a leading preventable cause of death in hospitals worldwide.

HART INNOVATIONS is hoping to utilise its current offering thanks to help from American contacts.